Diametric Capital, LP - ETON PHARMACEUTICALS INC ownership

ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 13 filers reported holding ETON PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Diametric Capital, LP ownership history of ETON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$363,000
-13.6%
49,536
-4.1%
0.28%
-16.8%
Q4 2020$420,000
+70.7%
51,633
+65.8%
0.33%
+82.5%
Q3 2020$246,000
-80.4%
31,149
-86.4%
0.18%
-81.0%
Q2 2020$1,253,000
-32.4%
229,819
-49.2%
0.96%
-57.3%
Q1 2020$1,854,000
+80.0%
452,103
+177.3%
2.25%
+164.8%
Q3 2019$1,030,000
-9.7%
163,033
+12.8%
0.85%
+17.3%
Q2 2019$1,141,000
+17.0%
144,493
+18.6%
0.72%
-5.4%
Q1 2019$975,000
+170.1%
121,873
+106.6%
0.76%
+174.2%
Q4 2018$361,00059,0020.28%
Other shareholders
ETON PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 449,438$1,928,0002.57%
Opaleye Management Inc. 2,385,000$10,232,0002.17%
AWM Investment Company, Inc. 500,000$2,145,0000.22%
GSA CAPITAL PARTNERS LLP 39,817$171,0000.02%
PARADIGM CAPITAL MANAGEMENT INC/NY 90,000$386,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 203,263$872,0000.02%
CHICAGO TRUST Co NA 16,700$72,0000.01%
Financial Advisors Network, Inc. 10,633$46,0000.01%
Westside Investment Management, Inc. 118,525$3,026,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 28,561$123,0000.00%
View complete list of ETON PHARMACEUTICALS INC shareholders